Cancer Therapy Advisor (4/23, Nam) reports that research indicates “accelerated partial breast irradiation (APBI) with multicatheter brachytherapy does not affect long-term quality of life (QoL) compared with whole-breast irradiation among patients with breast cancer who undergo breast-conserving surgery.” The findings were published in The Lancet Oncology.
The Radiology Business Journal (4/23, Slachta) reports that research suggests “low-risk breast cancer patients who opt for accelerated partial breast irradiation – a one-week alternative to traditional whole-breast radiotherapy – see the same quality of life as women who undergo conventional treatment.” The findings were presented at the European Society for Radiotherapy and Oncology Congress.
HealthImaging (4/20, Rohman) reported that research suggests “obligate overdiagnosis rates of mammographic screenings are strongly dependent on a women’s age at the time of the noninvasive breast exam.” The findings were published in Radiology.
Aunt Minnie (4/20, Yee) reported that while “studies show that the benefits of screening mammography outweigh its radiation risks, yet women continue to express concern about the radiation from mammography, often through social media and particularly on Twitter, according to research published online...in the Journal of the American College of Radiology.” The researchers wrote, “Healthcare professionals, academics, and scientific organizations should employ Twitter in their communication with the public more systematically and emphasize the harms of noncompliance with current guidelines for breast cancer screening over the fear of the theoretical radiogenic risk.”
Aunt Minnie (4/19, Yee) reports that according to a study published online April 10 in Radiology, “double reading of mammography screening exams – and using a third reader or a consensus process to resolve any interpretation discrepancies – increases the number of cancers detected and reduces recalls.” Use of a second radiology reader in breast cancer screening “can increase the number of cancers detected,” the researchers wrote, adding, “However, the clinical importance of these cancers requires careful consideration, as some may be overdiagnosed.”